Envue Medical Inc (FEED) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Envue Medical Inc   (NASDAQ: FEED)

Select the Financial Report: Select the Period:


Description of Envue Medical Inc's Business Segments
The Company operates through two primary segments: NanoVibronix and ENvue. NanoVibronix generates revenue by selling products directly to patients and through distributor agreements. ENvue generates revenue from sales of its Systems and Nasoenteral tubes. Non-allocated administrative and other expenses are reported under Corporate. The Chief Executive Officer, serving as the Chief Operating Decision Maker (CODM), reviews financial information by segment to allocate resources and assess performance based on each segment's loss from operations.

Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Composition of Envue Medical Inc Revenues by Segments
 
Related Party    108.42 % of total Revenue
Nano Vibronix    110.72 % of total Revenue
ENvue    48.85 % of total Revenue
UNITED STATES    75.04 % of total Revenue
Europe    25.88 % of total Revenue

Q1 three months ended (Mar 31 2026)
Revenues by Business Segments Revenues
(in millions $)		 %
(of total Revenues)
Related Party 0.71 108.42 %
Nano Vibronix 0.72 110.72 %
ENvue 0.32 48.85 %
UNITED STATES 0.49 75.04 %
Europe 0.17 25.88 %
Total 0.65 100 %




Q1 three months ended (Mar 31 2026)
Revenue Growth rates by Segment Y/Y Revenue
%		 Q/Q Revenue
%
Related Party -30.93 % -
Nano Vibronix -21.58 % -
ENvue 209.71 % -
UNITED STATES -50.3 % -
Europe 1777.78 % -
Total - -




Q1 three months ended (Mar 31 2026)
Income by Business Segments Income
(in millions $)		 %
(Profit Margin)
Total -22.00 -




Q1 three months ended (Mar 31 2026)
Income Growth rates by Segment Y/Y Income
%		 Q/Q Income
%
Total - -




Annual Report on Envue Medical Inc Divisions, Sales by Country

 
Related Party   Related Party Segment contribution to total sales 118.58 % of total Revenue
Nano Vibronix   Nano Vibronix Segment contribution to total sales 86.25 % of total Revenue
ENvue   ENvue Segment contribution to total sales 47.84 % of total Revenue
UNITED STATES   UNITED STATES Segment contribution to total sales 116.58 % of total Revenue
Europe   Europe Segment contribution to total sales 0.37 % of total Revenue
Other Country   Other Country Segment contribution to total sales 0.7 % of total Revenue
Australia New Zealand   Australia New Zealand Segment contribution to total sales 0.93 % of total Revenue


Twelve months ended 2025
FEED s Annual Revenue by Geography and Business Segments Sales
(in millions $)		 %
(of total Sales)
Related Party 2.55 118.58 %
Nano Vibronix 1.86 86.25 %
ENvue 1.03 47.84 %
UNITED STATES 2.51 116.58 %
Europe 0.01 0.37 %
Total 2.15 100 %
Other Country 0.02 0.7 %
Australia New Zealand 0.02 0.93 %


Twelve months ended 2025
FEED s Annual Income by Country and Business Segments Income
(in millions $)		 %
(Profit Margin)
Total -15.08 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Related Party -0.2 % -
Nano Vibronix -27.4 % -
UNITED STATES 2.45 % -
Europe -52.94 % -
Other Country -70 % -
Australia New Zealand -51.22 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.